Neovacs S.A. (EPA:ALNEV)
France · Delayed Price · Currency is EUR 0.2020
-0.0180 (-8.18%)
Sep 22, 2026, 5:35 PM CET
Neovacs Market Cap
Neovacs has a market cap or net worth of €32.13 thousand as of September 22, 2026. Its market cap has decreased by -72.64% in one year.
Market Cap
32.13K
Enterprise Value
164.28K
Revenue
199.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.20
ChartMarket Cap Chart
Since June 2, 2025, Neovacs's market cap has decreased from 600.00K to 32.13K, a decrease of -94.64%. That is a compound annual growth rate of -89.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 32.13K | 685.98% |
| Dec 31, 2025 | 4.09K | -99.32% |
| Jun 2, 2025 | 600.00K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biophytis | 17.16M |
| Aelis Farma | 11.83M |
| Advicenne | 11.51M |
| TME Pharma | 10.35M |
| Aton | 9.77M |
| Poxel | 9.75M |
| NFL Biosciences | 9.26M |
| Quantum Genomics Société Anonyme | 5.02M |